Novel FRET‐based Immunological Synapse Biosensor for the Prediction of Chimeric Antigen Receptor‐T Cell Function
Small Methods · 2025-03 · 9 (3)
DOI: 10.1002/smtd.202401016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, online erschienen am 11.09.2024. Verfasst von Hae Nim Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea. Hauptthemen laut MEDLINE: Fluorescence Resonance Energy Transfer, Biosensing Techniques, Receptors, Chimeric Antigen, Immunological Synapses. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Samsung Research Funding & Incubation Center of Samsung Electronics, National Research Foundation of Korea (NRF), Samsung.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR)‐T cell therapy has revolutionized cancer treatment. CARs are activated at the immunological synapse (IS) when their single‐chain variable fragment (scFv) domain engages with an antigen, allowing them to directly eliminate cancer cells. Here, an innovative IS biosensor based on fluorescence resonance energy transfer (FRET) for the real‐time assessment of CAR‐IS architecture and signaling competence is presented. Using this biosensor, scFv variants for mesothelin‐targeting CARs and identified as a novel scFv with enhanced CAR‐T cell functionality despite its lower affinity than the original screened. The original CAR promoted internalization and trogocytosis, disrupting stable IS formation and impairing functionality are further observed. These findings emphasize the importance of enhancing IS quality rather than maximizing scFv affinity for superior CAR‐T cell responses. Therefore, the FRET‐based IS biosensor is a powerful tool for predicting CAR‐T cell function, enabling the efficient engineering of next‐generation CARs with enhanced antitumor potency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
- Medical Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
- Wide River Institute of Immunology, Seoul National University, Hongcheon, 25159, Republic of Korea.
- BK21 FOUR Biomedical Science Project, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
- Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
ORCID-Profile: Jihye Seong
Förderung
- Samsung Research Funding & Incubation Center of Samsung Electronics
- National Research Foundation of Korea (NRF)
- Samsung
Zitieren
APA
Lee, H. N., Lee, S., Hong, J., Yoo, H., Jeong, J., Kim, Y. W., Shin, H. M., Jang, M., Lee, C. H., Kim, H. R., & Seong, J. (2025). Novel FRET‐based Immunological Synapse Biosensor for the Prediction of Chimeric Antigen Receptor‐T Cell Function. Small Methods, 9(3). https://doi.org/10.1002/smtd.202401016
Vancouver
Lee HN, Lee S, Hong J, Yoo H, Jeong J, Kim YW, et al. Novel FRET‐based Immunological Synapse Biosensor for the Prediction of Chimeric Antigen Receptor‐T Cell Function. Small Methods. 2025;9(3). doi:10.1002/smtd.202401016
BibTeX
@article{Lee2025,
author = {Lee, Hae Nim and Lee, Soojin and Hong, Jisu and Yoo, Hyejin and Jeong, Jiyun and Kim, Yong-Woo and Shin, Hyun Mu and Jang, Mihue and Lee, Chang-Han and Kim, Hang-Rae and Seong, Jihye},
title = {Novel FRET‐based Immunological Synapse Biosensor for the Prediction of Chimeric Antigen Receptor‐T Cell Function},
journal = {Small Methods},
year = {2025},
volume = {9},
number = {3},
doi = {10.1002/smtd.202401016}
}
EUVIMED